STRS Ohio’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

STRS Ohio’s Portfolio PEAR Stock Details PEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,900	Closed	-$4K	–	2176
2023 Q1	$4K	Hold	15,900	–	–	﹤0.01%	1924
2022 Q4	$18K	Hold	15,900	–	–	﹤0.01%	1894
2022 Q3	$32K	Buy	+15,900	New	+$27K	﹤0.01%	1891

STRS Ohio's PEAR Position: Q2 2023 in Review

STRS Ohio sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q2 2023, closing a stake of 15,900 shares — an estimated $4K sold.

STRS Ohio first reported a position in PEAR in Q3 2022 and held it in 3 quarters. The position peaked at $32K in Q3 2022. 1 fund tracked by Wall St. Rank holds PEAR as of Q2 2023.

STRS Ohio reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
STRS Ohio sold 15,900 Pear Therapeutics, Inc. Class A Common Stock shares in Q2 2023, an estimated $4K.
STRS Ohio first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 3 quarters.
STRS Ohio's Pear Therapeutics, Inc. Class A Common Stock position peaked at $32K in Q3 2022.
1 fund tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.